Cargando…
Nonviral Gene Therapy for Cancer: A Review
Although the development of effective viral vectors put gene therapy on the road to commercialization, nonviral vectors show promise for practical use because of their relative safety and lower cost. A significant barrier to the use of nonviral vectors, however, is that they have not yet proven effe...
Autores principales: | Hidai, Chiaki, Kitano, Hisataka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164850/ https://www.ncbi.nlm.nih.gov/pubmed/29970866 http://dx.doi.org/10.3390/diseases6030057 |
Ejemplares similares
-
Long-term gene therapy with Del1 fragment using nonviral vectors in mice with explanted tumors
por: Kitano, Hisataka, et al.
Publicado: (2016) -
EGF domain peptide of Developmentally regulated endothelial locus1 facilitates gene expression of extracellularly applied plasmid DNA
por: Kitano, Hisataka, et al.
Publicado: (2022) -
The Del1 deposition domain can immobilize 3α-hydroxysteroid dehydrogenase in the extracellular matrix without interfering with enzymatic activity
por: Hidai, Chiaki, et al.
Publicado: (2008) -
Targeted nonviral gene therapy in prostate cancer
por: Altwaijry, Najla, et al.
Publicado: (2018) -
The first EGF domain of coagulation factor IX attenuates cell adhesion and induces apoptosis
por: Ishikawa, Tomomi, et al.
Publicado: (2016)